12 Biggest Mid-Day Losers For Monday

Horizon Pharma PLC HZNP shares dipped 31.4 percent to $10.69 as the company posted downbeat Q1 earnings and lowered its FY 2017 guidance. The company also announced plans to acquire River Vision for $145 million in cash.
TherapeuticsMD Inc TXMD shares tumbled 18.2 percent to $3.82 after the company after the company announced it has received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration. The letter is in response to the company's New Drug Application (NDA) for its investigational applicator-free estradiol vaginal softgel capsule called TX-004HR. TherapeuticsMD said in its press release that while the letter didn't identify any issues related to the efficacy of the therapy, the FDA couldn't approve TX-004HR at this time. Specifically, the FDA cited a lack of long-term endometrial safety data beyond the 12-week period, which was explored in a Phase 3 clinical study called Rejoice Trial.
Innodata Inc INOD shares dropped 15.3 percent to $1.65. Innodata reported a Q1 loss of $0.07 per share on sales of $15 million.
Kite Pharma Inc KITE shares declined 13.1 percent to $71.07 as the company posted a wider-than-expected Q1 loss.
Workhorse Group Inc WKHS shares fell 12.2 percent to $3.18. Workhorse Group is expected to report Q1 financial results on Wednesday, May 10, 2017.
Akari Therapeutics PLC (ADR) AKTX shares dropped 11.7 percent to $11.64.
Aralez Pharmaceuticals Inc ARLZ shares tumbled 11.7 percent to $1.28.
Eyegate Pharmaceuticals Inc EYEG shares fell 8.2 percent to $1.90. EyeGate Pharmaceuticals reported Q1 net loss of $2.9 million on revenue of $0.19 million.
Digi International Inc. DGII declined 8 percent to $9.85. Belden Inc. BDC disclosed that it has rescinded its proposal to acquire Digi International for $13.82 per share in cash.
Hercules Capital Inc HTGC shares dropped 5.1 percent to $12.34. Wunderlich downgraded Hercules Capital from Buy to Hold.
Melco Resorts & Entertainment Ltd(ADR) MLCO shares fell 4.7 percent to $21.29 after the company reported the launch of an offer of ADSs and ordinary shares and concurrent repurchase of ordinary shares.
LyondellBasell Industries NV LYB shares declined 2.2 percent to $82.31. Analysts at Bank of America downgraded LyondellBasell from Neutral to Underperform.